Basic HTML Version
Ελληνική Ακτινολογία, Τόμος 43, Τεύχος 4, 2012
250
be tween dura l me tas tas i s and mening ioma.
Neuroradiology 2004;46(8):642–8.
120. Hakyemez B, Erdogan C, Ercan I, et al. High-grade and
low-grade gliomas: differentiation by using perfusion
MR imaging. Clin Radiol 2005;60(4):493–502.
121. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms:
dynamic contrast-enhanced T2*- weighted MR
imaging. Radiology 1999;211:791–8.
122. Sugahara T, Korogi Y, Kochi M, et al. Correlation
of MR imaging-determined cerebral blood volume
maps with histologic and angiographic determination
of vascularity of gliomas. AJR Am J Roentgenol
1998;171:1479–86.
123. Maia AC, Malheiros SM, da Rocha AJ, et al. MR
cerebral blood volume maps correlated with vascular
endothelial growth factor expression and tumor grade
in nonenhancing gliomas. AJNR Am J Neuroradiol
2005;26(4):777–83.
124. Shin JH, LeeHK, KwunBD, et al. Using relative cerebral
blood flow and volume to evaluate the histopathologic
grade of cerebral gliomas: preliminary results. AJR Am
J Roentgenol 2002;179(3):783–9.
125. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood
volume maps of gliomas: comparison with tumor grade
and histologic findings. Radiology 1994;191(1):41–
51.
126. Chaskis C, Stadnik T, Michotte A, et al. Prognos-
tic value of perfusion-weighted imaging in brain
glioma: a prospective study. ActaNeurochir (Wien)
2006;148(3):277–85 [comment: 285].
127. LupoJM,ChaS,ChangSM,etal.Dynamicsusceptibility-
weighted perfusion imaging of high-grade gliomas:
characterization of spatial heterogeneity. AJNR Am J
Neuroradiol 2005;26(6):1446–54.
128. Maia AC, Malheiros SM, da Rocha AJ, et al. Stereotactic
biopsy guidance in adul ts wi th supratentorial
nonenhancing gliomas: role of perfusion-weighted
magne t i c r e sonance imag i ng . J Neu r osu r g
2004;101(6):970–6.
129. Tsui EY, Chan JH, Leung TW, et al. Radionecrosis of
the temporal lobe: dynamic susceptibility contrast MRI.
Neuroradiology 2000;42(2):149–52.
130. Siegal T, Rubinstein R, Tzuk-Shina T, et al. Utility of
relative cerebral blood volume mapping derived from
perfusion magnetic resonance imaging in the routine
follow up of brain tumors. J Neurosurg 1997;86(1):22–
7.
131. Sugahara T, Korog i Y, Tomi guch i S, e t a l .
Posttherapeutic intraaxial brain tumor: the value of
perfusion-sensitive contrast-enhanced MR imaging for
differentiating tumor recurrence from nonneoplastic
contrast-enhancing tissue. AJNR Am J Neuroradiol
2000;21(5):901–9.
132. Ostergaard L, Hochberg FH, Rabinov JD, et al. Early
changes measured by magnetic resonance imaging
in cerebral blood flow, blood volume, and blood-
brain barrier permeability following dexamethasone
treatment in patients with brain tumors. J Neurosurg
1999;90(2):300–5.
133. Wi l k i nson ID, Je l l i neck DA, Levy D, e t a l .
Dexamethasone and enhancing solitary cerebral mass
lesions: alterations in perfusion and blood-tumor
barrier kinetics shown by magnetic resonance imaging.
Neurosurgery 2006;58(4):640–6.
134. Roberts HC, Roberts TP, Ley S, et al. Quantitative
estimation of microvascular permeability in human
brain tumors: correlation of dynamic Gd-DTPA-
enhanced MRimaging with histopathologic grading.
Acad Radiol 2002;9(Suppl 1):S151–5.
135. Hazle JD, Jackson EF, Schomer DF, et al. Dynamic
imaging of intracranial lesions using fast spin-echo
imaging: differentiation of brain tumors and treatment
effects. JMagn Reson Imaging 1997;7(6):1084–93.
136. Uematsu H, Maeda M, Sadato N, et al. Vascular
permeability: quantitative measurement with double-
echo dynamic MR imaging - theory and clinical
application. Radiology 2000;214:912–7.
137. RobertsHC, Roberts TPL, BraschRC, et al.Quantitative
measurement of microvascular permeability in human
brain tumors achieved using dynamic contrast-
enhanced MR imaging: correlation with histologic
grade. AJNR Am J Neuroradiol 2000;21:891–9.
138. Provenzale JM,WangGR, Brenner T, et al. Comparison
of permeability in high-grade and low-grade brain
tumors using dynamic susceptibility contrast MR
imaging. AJR Am J Roentgenol 2002;178:711–6.
139. Law M, Yang S, Babb JS, et al. Comparison of
cerebral blood volume and vascular permeability from
dynamic susceptibility contrast enhanced perfusion MR
imaging with glioma grade. AJNR Am J Neuroradiol
2003;25:746–55.
140. Law M, Young R, Babb J, et al. Comparing perfusion
metrics obtained from a single compartment versus
pharmacokinetic modeling methods using dynamic
susceptibility contrastenhanced perfusion MR imaging
withgliomagrade. AJNRAmJNeuroradiol 2006;27(9):
1975–82.
141. Jackson A, Kassner A, Annesley-Williams D, et al.
Abnormalities in the recirculation phase of contrast
agent bolus passage in cerebral gliomas: comparison
with relative blood volume and tumor grade. AJNR
Am J Neuroradiol 2002;23(1):7–14.
142. Provenzale JM, York G, Moya MG, et al. Correlation
of relative permeability and relative cerebral blood
volume in high-grade cerebral neoplasms. AJR Am J
Roentgenol 2006; 187(4):1036–42.
143. Preusser M, Haberler C, Hainfellner JA. Malignant
glioma: neuropathology and neurobiology [review].
Wien Med Wochenschr 2006;156(11–12):332–7.
144. Law M, Oh S, Babb JS, et al. Low-grade gliomas:
dynamic susceptibility-weighted contrast enhanced
perfusion MR imaging prediction of patient clinical
response. Radiology 2006; 238(2):658–67.